CIS is a potent checkpoint in NK cell-mediated tumor immunity (vol 17, pg 816, 2016)

被引:0
|
作者
Delconte, Rebecca B.
Kolesnik, Tatiana B.
Dagley, Laura F.
Rautela, Jai
Shi, Wei
Putz, Eva M.
Stannard, Kimberley
Zhang, Jian-Guo
Teh, Charis
Firth, Matt
Ushiki, Takashi
Andoniou, Christopher E.
Degli-Esposti, Mariapia A.
Sharp, Phillip P.
Sanvitale, Caroline E.
Infusini, Giuseppe
Liau, Nicholas P. D.
Linossi, Edmond M.
Burns, Christopher J.
Carotta, Sebastian
Gray, Daniel H. D.
Seillet, Cyril
Hutchinson, Dana S.
Belz, Gabrielle T.
Webb, Andrew I.
Alexander, Warren S.
Li, Shawn S.
Bullock, Alex N.
Babon, Jeffrey J.
Smyth, Mark J.
Nicholson, Sandra E.
Huntington, Nicholas D.
机构
[1] The Walter and Eliza Hall Institute of Medical Research,Department of Medical Biology
[2] The University of Melbourne,Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia and Centre for Experimental Immunology
[3] Immunology in Cancer and Infection Laboratory QIMR Berghofer Medical Research Institute,Structural Genomics Consortium (SGC)
[4] Lions Eye Institute,Monash Institute of Pharmaceutical Sciences
[5] University of Oxford,Department of Biochemistry and the Siebens
[6] Monash University,Drake Medical Research Institute, Schulich School of Medicine and Dentistry
[7] University of Western Ontario,School of Medicine
[8] University of Queensland,undefined
关键词
D O I
10.1038/s41590-023-01714-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:371 / 372
页数:2
相关论文
共 50 条
  • [11] Tumor escape front NK cell-mediated destruction
    Repp, A
    Mayhew, ES
    Apte, S
    Niederkorn, JY
    FASEB JOURNAL, 2000, 14 (06): : A1010 - A1010
  • [12] Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
    Qing Zhang
    Jiacheng Bi
    Xiaodong Zheng
    Yongyan Chen
    Hua Wang
    Wenyong Wu
    Zhengguang Wang
    Qiang Wu
    Hui Peng
    Haiming Wei
    Rui Sun
    Zhigang Tian
    Nature Immunology, 2018, 19 : 723 - 732
  • [13] Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
    Zhang, Qing
    Bi, Jiacheng
    Zheng, Xiaodong
    Chen, Yongyan
    Wang, Hua
    Wu, Wenyong
    Wang, Zhengguang
    Wu, Qiang
    Peng, Hui
    Wei, Haiming
    Sun, Rui
    Tian, Zhigang
    NATURE IMMUNOLOGY, 2018, 19 (07) : 723 - +
  • [14] Mechanisms of Tumor Evasion from NK Cell-Mediated Immunity hi Pediatric HTx Patients with PTLD
    Wiesmayr, S.
    Webber, S. A.
    Smith, I. G.
    Popescu, I.
    Alacedo, C.
    Metes, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S251 - S252
  • [15] VIRAL ENHANCEMENT OF T CELL-MEDIATED TUMOR IMMUNITY
    REINISCH, CL
    BOCHNER, S
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 974 - 974
  • [16] Cell-Mediated Immunity in Host after Tumor Irradiation
    Tsuchiya, Takehiko
    Norimura, Toshiyuki
    Okamoto, Mieko
    1600, Oxford University Press (24):
  • [17] NKG2D in NK and T cell-mediated immunity
    Ogasawara, K
    Lanier, LL
    JOURNAL OF CLINICAL IMMUNOLOGY, 2005, 25 (06) : 534 - 540
  • [18] NKG2D in NK and T Cell-Mediated Immunity
    Kouetsu Ogasawara
    Lewis L. Lanier
    Journal of Clinical Immunology, 2005, 25 : 534 - 540
  • [19] Artemisinin sensitizes tumor cells to NK cell-mediated cytolysis
    Lu, Zhen
    Bi, Jiacheng
    Wan, Xiaochun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 524 (02) : 418 - 423
  • [20] NK Cell-Mediated Processing Of Chlamydia psittaci Drives Potent Anti-Bacterial Th1 Immunity
    Nadine Radomski
    Kati Franzke
    Svea Matthiesen
    Axel Karger
    Michael R. Knittler
    Scientific Reports, 9